• Decrease font size
  • Return font size to normal
  • Increase font size
U.S. Department of Health and Human Services

Device Classification Under Section 513(f)(2)(De Novo)

  • Print
  • Share
  • E-mail
-
Super Search Devices@FDA
510(k) | DeNovo | Registration & Listing | Adverse Events | Recalls | PMA | HDE | Classification | Standards
CFR Title 21 | Radiation-Emitting Products | X-Ray Assembler | Medsun Reports | CLIA | TPLC
 


New Search Back to Search Results
Device Classification Name circulating tumor cell (ctc) enrichment device
De Novo Number DEN200062
Device Name Parsortix PC1 Device
Requester
angle europe , ltd.
10 nugent rd.
guildford,  GB gu2 7af
Contact andrew newland
Regulation Number866.6110
Classification Product Code
QSA  
Date Received09/28/2020
Decision Date 05/24/2022
Decision granted (DENG)
Classification Advisory Committee Immunology
Review Advisory Committee Molecular Genetics
Classification Order Classification Order
FDA Review Decision Summary
Type Direct
Predetermined Change
Control Plan Authorized
No
-
-